India’s pharmaceutical sector is on the rise, and the government has set a bold target—**reaching \$100 billion by 2025**. This ambitious goal is part of a broader plan to establish **India as a global hub for pharmaceutical and medical device manufacturing**.
During a recent event organized by **FICCI in Ahmedabad**, Union Minister of Chemicals and Fertilizers, **Mr. D V Sadananda Gowda**, highlighted the country’s strong position in the global pharma landscape. “The Indian pharmaceuticals and medical devices sector has the potential to become a world leader,” he said, assuring full support from the government to achieve this vision.
---
Why This Matters for the Industry
India is already known for its high-quality and affordable medicines. The minister emphasized that, especially in developing countries, **affordable healthcare is a major concern**, and India is playing a vital role in solving this issue by supplying cost-effective drugs and diagnostics.
To support this growth, the government is focusing on **key policy interventions**. These include:
* Boosting research and development (R\&D)** through stronger collaboration between academia and industry
* Developing a robust manufacturing ecosystem** for pharmaceuticals and medical devices
* Creating infrastructure** like specialized industrial parks for bulk drugs and medical devices
---
Gujarat Takes the Lead
Gujarat is emerging as a frontrunner in India’s pharma journey. **Chief Minister Vijay Rupani** announced the state’s plan to develop **two dedicated industrial parks**—one for **bulk drug manufacturing** and the other for **medical devices**. This will further boost the local industry and generate new opportunities for manufacturers, suppliers, and healthcare innovators.
---
At Star Filtration Systems: Supporting India’s Pharma Vision
At **Star Filtration Systems**, we proudly contribute to India’s pharma mission by offering **end-to-end third-party manufacturing solutions** for:
* **Tablets**
* **Capsules**
* **Syrups**
* **Ointments**
With a focus on **quality, innovation, and timely delivery**, we are committed to supporting our partners as they scale their operations in this exciting growth phase for the Indian pharmaceutical industry.
---
Conclusion
India's goal of becoming a \$100 billion pharma industry by 2025 is not just a dream—it’s a growing reality backed by strong government support, industry innovation, and infrastructural development. With stakeholders across the country working together, the future of Indian pharma looks brighter than ever